122 related articles for article (PubMed ID: 15267237)
21. Investigation of glucose binding sites on insulin.
Zoete V; Meuwly M; Karplus M
Proteins; 2004 May; 55(3):568-81. PubMed ID: 15103621
[TBL] [Abstract][Full Text] [Related]
22. Rational design of peptide ligand for affinity chromatography of tissue-type plasminogen activator by the combination of docking and molecular dynamics simulations.
Liu FF; Dong XY; Wang T; Sun Y
J Chromatogr A; 2007 Dec; 1175(2):249-58. PubMed ID: 17996243
[TBL] [Abstract][Full Text] [Related]
23. Molecular insight into pseudolysin inhibition using the MM-PBSA and LIE methods.
Adekoya OA; Willassen NP; Sylte I
J Struct Biol; 2006 Feb; 153(2):129-44. PubMed ID: 16376106
[TBL] [Abstract][Full Text] [Related]
24. A computational investigation of allostery in the catabolite activator protein.
Li L; Uversky VN; Dunker AK; Meroueh SO
J Am Chem Soc; 2007 Dec; 129(50):15668-76. PubMed ID: 18041838
[TBL] [Abstract][Full Text] [Related]
25. Structure-activity relationships and binding mode in the human acetylcholinesterase active site of pseudo-irreversible inhibitors related to xanthostigmine.
Rizzo S; Cavalli A; Ceccarini L; Bartolini M; Belluti F; Bisi A; Andrisano V; Recanatini M; Rampa A
ChemMedChem; 2009 Apr; 4(4):670-9. PubMed ID: 19222043
[TBL] [Abstract][Full Text] [Related]
26. Crystallographic and computational studies on 4-phenyl-N-(beta-D-glucopyranosyl)-1H-1,2,3-triazole-1-acetamide, an inhibitor of glycogen phosphorylase: comparison with alpha-D-glucose, N-acetyl-beta-D-glucopyranosylamine and N-benzoyl-N'-beta-D-glucopyranosyl urea binding.
Alexacou KM; Hayes JM; Tiraidis C; Zographos SE; Leonidas DD; Chrysina ED; Archontis G; Oikonomakos NG; Paul JV; Varghese B; Loganathan D
Proteins; 2008 May; 71(3):1307-23. PubMed ID: 18041758
[TBL] [Abstract][Full Text] [Related]
27. Acetylcholinesterase: mechanisms of covalent inhibition of wild-type and H447I mutant determined by computational analyses.
Cheng Y; Cheng X; Radić Z; McCammon JA
J Am Chem Soc; 2007 May; 129(20):6562-70. PubMed ID: 17461584
[TBL] [Abstract][Full Text] [Related]
28. Heterocyclic inhibitors of AChE acylation and peripheral sites.
Bolognesi ML; Andrisano V; Bartolini M; Cavalli A; Minarini A; Recanatini M; Rosini M; Tumiatti V; Melchiorre C
Farmaco; 2005; 60(6-7):465-73. PubMed ID: 15878569
[TBL] [Abstract][Full Text] [Related]
29. Molecular dynamics-solvated interaction energy studies of protein-protein interactions: the MP1-p14 scaffolding complex.
Cui Q; Sulea T; Schrag JD; Munger C; Hung MN; Naïm M; Cygler M; Purisima EO
J Mol Biol; 2008 Jun; 379(4):787-802. PubMed ID: 18479705
[TBL] [Abstract][Full Text] [Related]
30. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations.
Durdagi S; Mavromoustakos T; Chronakis N; Papadopoulos MG
Bioorg Med Chem; 2008 Dec; 16(23):9957-74. PubMed ID: 18996019
[TBL] [Abstract][Full Text] [Related]
31. Induced fit in mouse acetylcholinesterase upon binding a femtomolar inhibitor: a molecular dynamics study.
Senapati S; Bui JM; McCammon JA
J Med Chem; 2005 Dec; 48(26):8155-62. PubMed ID: 16366597
[TBL] [Abstract][Full Text] [Related]
32. Computational study of IAG-nucleoside hydrolase: determination of the preferred ground state conformation and the role of active site residues.
Mazumder-Shivakumar D; Bruice TC
Biochemistry; 2005 May; 44(21):7805-17. PubMed ID: 15909995
[TBL] [Abstract][Full Text] [Related]
33. Allosteric modulation of acetylcholinesterase activity by peripheral ligands involves a conformational transition of the anionic subsite.
Barak D; Ordentlich A; Bromberg A; Kronman C; Marcus D; Lazar A; Ariel N; Velan B; Shafferman A
Biochemistry; 1995 Nov; 34(47):15444-52. PubMed ID: 7492545
[TBL] [Abstract][Full Text] [Related]
34. Assessment of multiple binding modes in ligand-protein docking.
Källblad P; Mancera RL; Todorov NP
J Med Chem; 2004 Jun; 47(13):3334-7. PubMed ID: 15189030
[TBL] [Abstract][Full Text] [Related]
35. Computational studies of the binding mechanism of calmodulin with chrysin.
Li L; Wei DQ; Wang JF; Chou KC
Biochem Biophys Res Commun; 2007 Jul; 358(4):1102-7. PubMed ID: 17521610
[TBL] [Abstract][Full Text] [Related]
36. A novel approach to local similarity of protein binding sites substantially improves computational drug design results.
Ramensky V; Sobol A; Zaitseva N; Rubinov A; Zosimov V
Proteins; 2007 Nov; 69(2):349-57. PubMed ID: 17623865
[TBL] [Abstract][Full Text] [Related]
37. Effect of crystal freezing and small-molecule binding on internal cavity size in a large protein: X-ray and docking studies of lipoxygenase at ambient and low temperature at 2.0 A resolution.
Skrzypczak-Jankun E; Borbulevych OY; Zavodszky MI; Baranski MR; Padmanabhan K; Petricek V; Jankun J
Acta Crystallogr D Biol Crystallogr; 2006 Jul; 62(Pt 7):766-75. PubMed ID: 16790932
[TBL] [Abstract][Full Text] [Related]
38. Molecular modeling, dynamics and docking studies of purine nucleoside phosphorylase from Streptococcus pyogenes.
Timmers LF; Caceres RA; Dias R; Basso LA; Santos DS; de Azevedo WF
Biophys Chem; 2009 Jun; 142(1-3):7-16. PubMed ID: 19282092
[TBL] [Abstract][Full Text] [Related]
39. Molecular dynamics simulations of human butyrylcholinesterase.
Suárez D; Field MJ
Proteins; 2005 Apr; 59(1):104-17. PubMed ID: 15696543
[TBL] [Abstract][Full Text] [Related]
40. Molecular docking for substrate identification: the short-chain dehydrogenases/reductases.
Favia AD; Nobeli I; Glaser F; Thornton JM
J Mol Biol; 2008 Jan; 375(3):855-74. PubMed ID: 18036612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
